Cargando…
The impact of COVID-19 on managing ophthalmic diseases: an international, descriptive study
BACKGROUND: Anecdotally, the COVID-19 pandemic has resulted in more severe cases of eye disease, decreased medication compliance/availability, and decreased treatment volume due to the lockdown. AIMS: We aim to quantify and bring together a variety of international perspectives from ophthalmologists...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918813/ https://www.ncbi.nlm.nih.gov/pubmed/36773204 http://dx.doi.org/10.1007/s11845-023-03306-9 |
_version_ | 1785145834813259776 |
---|---|
author | Waisberg, Ethan Ong, Joshua Zaman, Nasif Kamran, Sharif Amit Tavakkoli, Alireza Lee, Andrew G. |
author_facet | Waisberg, Ethan Ong, Joshua Zaman, Nasif Kamran, Sharif Amit Tavakkoli, Alireza Lee, Andrew G. |
author_sort | Waisberg, Ethan |
collection | PubMed |
description | BACKGROUND: Anecdotally, the COVID-19 pandemic has resulted in more severe cases of eye disease, decreased medication compliance/availability, and decreased treatment volume due to the lockdown. AIMS: We aim to quantify and bring together a variety of international perspectives from ophthalmologists of different subspecialties to characterize the global impact of COVID-19 on managing various ophthalmic disease. METHODS: An online survey of 10 questions was conducted among ophthalmologists using a specialized survey program. RESULTS: Fifty-two ophthalmologists were successfully contacted. Survey respondents include ophthalmologists from USA, Canada, Korea, Mexico, and New Zealand. Based on the results of our survey, 1 year after the pandemic, ophthalmic disease severity has worsened as well as a decrease in examination and medication compliance. CONCLUSIONS: Ophthalmologists across the world have reported a general increase in disease severity and decrease in medication and examination compliance 1 year after the beginning of COVID-19. |
format | Online Article Text |
id | pubmed-9918813 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-99188132023-12-03 The impact of COVID-19 on managing ophthalmic diseases: an international, descriptive study Waisberg, Ethan Ong, Joshua Zaman, Nasif Kamran, Sharif Amit Tavakkoli, Alireza Lee, Andrew G. Ir J Med Sci Brief Report BACKGROUND: Anecdotally, the COVID-19 pandemic has resulted in more severe cases of eye disease, decreased medication compliance/availability, and decreased treatment volume due to the lockdown. AIMS: We aim to quantify and bring together a variety of international perspectives from ophthalmologists of different subspecialties to characterize the global impact of COVID-19 on managing various ophthalmic disease. METHODS: An online survey of 10 questions was conducted among ophthalmologists using a specialized survey program. RESULTS: Fifty-two ophthalmologists were successfully contacted. Survey respondents include ophthalmologists from USA, Canada, Korea, Mexico, and New Zealand. Based on the results of our survey, 1 year after the pandemic, ophthalmic disease severity has worsened as well as a decrease in examination and medication compliance. CONCLUSIONS: Ophthalmologists across the world have reported a general increase in disease severity and decrease in medication and examination compliance 1 year after the beginning of COVID-19. Springer International Publishing 2023-02-11 2023 /pmc/articles/PMC9918813/ /pubmed/36773204 http://dx.doi.org/10.1007/s11845-023-03306-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Brief Report Waisberg, Ethan Ong, Joshua Zaman, Nasif Kamran, Sharif Amit Tavakkoli, Alireza Lee, Andrew G. The impact of COVID-19 on managing ophthalmic diseases: an international, descriptive study |
title | The impact of COVID-19 on managing ophthalmic diseases: an international, descriptive study |
title_full | The impact of COVID-19 on managing ophthalmic diseases: an international, descriptive study |
title_fullStr | The impact of COVID-19 on managing ophthalmic diseases: an international, descriptive study |
title_full_unstemmed | The impact of COVID-19 on managing ophthalmic diseases: an international, descriptive study |
title_short | The impact of COVID-19 on managing ophthalmic diseases: an international, descriptive study |
title_sort | impact of covid-19 on managing ophthalmic diseases: an international, descriptive study |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918813/ https://www.ncbi.nlm.nih.gov/pubmed/36773204 http://dx.doi.org/10.1007/s11845-023-03306-9 |
work_keys_str_mv | AT waisbergethan theimpactofcovid19onmanagingophthalmicdiseasesaninternationaldescriptivestudy AT ongjoshua theimpactofcovid19onmanagingophthalmicdiseasesaninternationaldescriptivestudy AT zamannasif theimpactofcovid19onmanagingophthalmicdiseasesaninternationaldescriptivestudy AT kamransharifamit theimpactofcovid19onmanagingophthalmicdiseasesaninternationaldescriptivestudy AT tavakkolialireza theimpactofcovid19onmanagingophthalmicdiseasesaninternationaldescriptivestudy AT leeandrewg theimpactofcovid19onmanagingophthalmicdiseasesaninternationaldescriptivestudy AT waisbergethan impactofcovid19onmanagingophthalmicdiseasesaninternationaldescriptivestudy AT ongjoshua impactofcovid19onmanagingophthalmicdiseasesaninternationaldescriptivestudy AT zamannasif impactofcovid19onmanagingophthalmicdiseasesaninternationaldescriptivestudy AT kamransharifamit impactofcovid19onmanagingophthalmicdiseasesaninternationaldescriptivestudy AT tavakkolialireza impactofcovid19onmanagingophthalmicdiseasesaninternationaldescriptivestudy AT leeandrewg impactofcovid19onmanagingophthalmicdiseasesaninternationaldescriptivestudy |